13F Insight
DOSSIER · 13F Holders · Q3 2025Healthcare · Biotechnology
VRNA

VERONA PHARMA PLC

6 institutions still hold VERONA PHARMA PLC as of Q3 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 925050106·Biotechnology·6 13F holders·last filed Sep 30, 2025
Market cap
—
13F value held
$10M
visible holders
Holders
6
filers reporting
Concentration
64.42%
Burren Capital Advisors Ltd #1
top holder share
AI Holders Summary · Q3 2025

6 institutions reported VRNA in Q3 2025. Burren Capital Advisors Ltd leads at 64.4% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Burren Capital Advisors Ltd
CIK 0001542952
$7M63K20.43%Q3 202502
WOLVERINE TRADING, LLC
CIK 0000927337
$3M27K0.00%Q3 202503
Cahill Wealth Management, LLC
CIK 0001927960
$512K8K0.26%Q1 202504
Orion Portfolio Solutions, LLC
CIK 0001802647
$249K4K0.00%Q1 202505
First Horizon Advisors, Inc.
CIK 0001588539
$108K1K0.00%Q2 202506
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025
Insiders at VERONA PHARMA PLC
Ullman Anders →Fisher Andrew →Rickard Kathleen A. →Austwick Michael →Deschamps Lisa →Brady James Aloysius →Cunningham Kenneth →